We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-0.03%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.2B
AUM Growth
+$10.2B
Cap. Flow
+$1.69B
Cap. Flow %
16.49%
Top 10 Hldgs %
49.38%
Holding
721
New
55
Increased
105
Reduced
258
Closed
39

Sector Composition

Rank Sector Weight
1 Energy 67.58%
2 Financials 2.55%
3 Healthcare 2.33%
4 Materials 1.85%
5 Technology 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCMP
201
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$1.35M 0.01%
78,386
-11,120
-12% -$199K
KIM icon
202
Kimco Realty
KIM
$17.6B
$1.34M 0.01%
50,724
-1,509
-3% -$39.3K
MAC icon
203
Macerich
MAC
$7.32B
$1.33M 0.01%
16,508
-1,261
-7% -$101K
EXR icon
204
Extra Space Storage
EXR
$31.2B
$1.32M 0.01%
14,920
-730
-5% -$60K
TRGP icon
205
Targa Resources
TRGP
$60.4B
$1.29M 0.01%
47,689
+19,369
+68% +$859K
RVNC
206
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.26M 0.01%
36,968
-513
-1% -$17.8K
SSRI
207
DELISTED
Silver Standard Resources
SSRI
$1.24M 0.01%
238,888
-26,376
-10% -$159K
FRT icon
208
Federal Realty Investment Trust
FRT
$10.9B
$1.23M 0.01%
8,429
-286
-3% -$41.3K
DVAX
209
DELISTED
Dynavax Technologies
DVAX
$1.22M 0.01%
+50,618
New +$1.27M
ENTA icon
210
Enanta Pharmaceuticals
ENTA
$372M
$1.21M 0.01%
36,534
-4,640
-11% -$151K
UDR icon
211
UDR
UDR
$12.9B
$1.21M 0.01%
32,068
-704
-2% -$25.3K
SUPN icon
212
Supernus Pharmaceuticals
SUPN
$2.68B
$1.2M 0.01%
89,179
-11,381
-11% -$176K
FWP
213
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$1.16M 0.01%
8,754
-1,647
-16% -$264K
SEMG
214
DELISTED
SEMGROUP CORPORATION
SEMG
$1.15M 0.01%
39,958
+15,857
+66% +$607K
PDLI
215
DELISTED
PDL BioPharma, Inc.
PDLI
$1.09M 0.01%
308,443
-41,493
-12% -$174K
AIMT
216
DELISTED
Aimmune Therapeutics
AIMT
$1.03M 0.01%
+55,657
New +$1.03M
BCRX icon
217
BioCryst Pharmaceuticals
BCRX
$2.37B
$997K 0.01%
+96,610
New +$961K
ATRA icon
218
Atara Biotherapeutics
ATRA
$71.2M
$996K 0.01%
1,509
-265
-15% -$200K
FSM icon
219
Fortuna Silver Mines
FSM
$2.59B
$990K 0.01%
440,106
-15,636
-3% -$39.1K
OMED
220
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$894K 0.01%
39,663
-7,323
-16% -$150K
OTIC
221
DELISTED
Otonomy, Inc.
OTIC
$886K 0.01%
31,929
-5,845
-15% -$145K
AERI
222
DELISTED
Aerie Pharmaceuticals
AERI
$846K 0.01%
34,732
-5,483
-14% -$128K
PAAS icon
223
Pan American Silver
PAAS
$18.6B
$843K 0.01%
129,734
-192,306
-60% -$1.38M
CDE icon
224
Coeur Mining
CDE
$15.6B
$833K 0.01%
335,897
-31,902
-9% -$87.1K
DE icon
225
Deere & Co
DE
$170B
$829K 0.01%
10,873
-4,105
-27% -$318K

Similar funds

ALPS Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, ALPS Advisors held 721 positions worth $10.2B, up 10,697% from $94.9M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

ALPS Advisors deployed $1.69B of net new capital in Q4 2015, opening 55 new positions and adding to 105 existing holdings. Its largest new stake was MPLX: 16,812,418 shares worth $661M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, down from 68% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Williams Partners L.P., an estimated $50.1M trimmed.

  • ALPS Advisors's largest Q4 2015 buy was MPLX: 16,812,418 shares worth $661M.
  • ALPS Advisors added most to Buckeye Partners, L.P. in Q4 2015, an estimated $192M increase.
  • ALPS Advisors's biggest Q4 2015 reduction was Williams Partners L.P., cutting an estimated $50.1M.
  • ALPS Advisors fully exited MARKWEST ENERGY PARTNERS, LP in Q4 2015, selling an estimated $4.85M.
  • ALPS Advisors's ten largest holdings make up 49% of its $10.2B portfolio in Q4 2015.
  • ALPS Advisors opened 55 new positions and closed 39 in Q4 2015.
  • ALPS Advisors's portfolio value rose 10,697% quarter-over-quarter to $10.2B.

Based on ALPS Advisors's 13F filing for Q4 2015, filed 5 Feb 2016.